Outcomes of patients with myocardial infarction and cardiogenic
shock treated with culprit vessel-only versus multivessel
primary PCI

ENPřihlásit se Přihlásit se (EduID)

Outcomes of patients with myocardial infarction and cardiogenic shock treated with culprit ...

Přehled o publikaci

J 2024

Outcomes of patients with myocardial infarction and cardiogenic shock treated with culprit vessel-only versus multivessel primary PCI

HLINOMAZ, Ota, Zuzana MOTOVSKA, Petr KALA, Milan HROMADKA, Jan PRECEK et. al.

Základní údaje

Originální název

Outcomes of patients with myocardial infarction and cardiogenic shock treated with culprit vessel-only versus multivessel primary PCI

Autoři

HLINOMAZ, Ota, Zuzana MOTOVSKA, Petr KALA, Milan HROMADKA, Jan PRECEK, Jan MROZEK, Pavel ČERVINKA, Jiri KETTNER, Jan MATEJKA, Ahmad ZOHOOR, Josef BIS a Jiří JARKOVSKÝ

Vydání

Hellenic Journal of Cardiology, AMSTERDAM, ELSEVIER, 2024, 1109-9666

Další údaje

Jazyk

angličtina

Typ výsledku

Článek v odborném periodiku

Stát vydavatele

Nizozemské království

Utajení

není předmětem státního či obchodního tajemství

Odkazy

URL

Organizace

Lékařská fakulta – Masarykova univerzita – Repozitář

DOI

http://dx.doi.org/10.1016/j.hjc.2023.08.009

UT WoS

001227067900001

EID Scopus

2-s2.0-85170086758

Klíčová slova anglicky

Acute myocardial infarction; Cardiogenic shock; Multivessel disease; Culprit vessel primary angioplasty; Multivessel primary angioplasty

Návaznosti

LM2023049, projekt VaV. LX22NPO5104, projekt VaV. NV19-02-00086, projekt VaV.

Změněno: 22. 1. 2025 00:50, RNDr. Daniel Jakubík

Anotace

V originále

lt; 0.001). Intra-aortic balloon pump, extracorporeal membrane oxygenation (ECMO), and other mechanical circulatory support systems were more often used in patients with MV-pPCI. Thirty (30)-day and 1-year all-cause mortality rates were similar in the CV-pPCI and MV-pPCI groups (odds ratio, 1.01; 95% confidence interval [CI] 0.77 to 1.32; p = 0.937 and 1.1; 95% CI 0.84 to 1.44; p = 0.477). The presence of 3-vessel disease and the use of ECMO were the strongest adjusted predictors of 30-day and 1-year mortality. Conclusions Our data from an extensive all-comers registry suggests that selective use of MV-pPCI does not increase the all-cause mortality rate in patients with CS-STEMI and MVD compared to CV-pPCI.

Přiložené soubory

https://is.muni.cz/publication/2362487/Outcomes_of_patients_with_myocardial_infarction_and_cardiogenic_shock_treated_with_culprit_vessel-only_versus_multivessel_primary_PCI.pdf

https://is.muni.cz/publication/2362487/Outcomes_of_patients_with_myocardial_infarction_and_cardiogenic_shock_treated_with_culprit_vessel-only_versus_multivessel_primary_PCI_nivdlarz.pdf

Citovat

HLINOMAZ, Ota, Zuzana MOTOVSKA, Petr KALA, Milan HROMADKA, Jan PRECEK, Jan MROZEK, Pavel ČERVINKA, Jiri KETTNER, Jan MATEJKA, Ahmad ZOHOOR, Josef BIS a Jiří JARKOVSKÝ. Outcomes of patients with myocardial infarction and cardiogenic shock treated with culprit vessel-only versus multivessel primary PCI. Hellenic Journal of Cardiology. AMSTERDAM: ELSEVIER, 2024, roč. 76, March-April 2024, s. 1-10. ISSN 1109-9666. Dostupné z: https://dx.doi.org/10.1016/j.hjc.2023.08.009.

@article{59287,
   author = {Hlinomaz, Ota and Motovska, Zuzana and Kala, Petr and Hromadka, Milan and Precek, Jan and Mrozek, Jan and Červinka, Pavel and Kettner, Jiri and Matejka, Jan and Zohoor, Ahmad and Bis, Josef and Jarkovský, Jiří},
   article_location = {AMSTERDAM},
   article_number = {March-April 2024},
   doi = {http://dx.doi.org/10.1016/j.hjc.2023.08.009},
   keywords = {Acute myocardial infarction; Cardiogenic shock; Multivessel disease; Culprit vessel primary angioplasty; Multivessel primary angioplasty},
   language = {eng},
   issn = {1109-9666},
   journal = {Hellenic Journal of Cardiology},
   title = {Outcomes of patients with myocardial infarction and cardiogenic shock treated with culprit vessel-only versus multivessel primary PCI},
   url = {https://www.sciencedirect.com/science/article/pii/S110996662300146X?via%3Dihub},
   volume = {76},
   year = {2024}
}

TY  - JOUR
ID  - 59287
AU  - Hlinomaz, Ota - Motovska, Zuzana - Kala, Petr - Hromadka, Milan - Precek, Jan - Mrozek, Jan - Červinka, Pavel - Kettner, Jiri - Matejka, Jan - Zohoor, Ahmad - Bis, Josef - Jarkovský, Jiří
PY  - 2024
TI  - Outcomes of patients with myocardial infarction and cardiogenic shock treated with culprit vessel-only versus multivessel primary PCI
JF  - Hellenic Journal of Cardiology
VL  - 76
IS  - March-April 2024
SP  - 1-10
EP  - 1-10
PB  - ELSEVIER
SN  - 1109-9666
KW  - Acute myocardial infarction
KW  - Cardiogenic shock
KW  - Multivessel disease
KW  - Culprit vessel primary angioplasty
KW  - Multivessel primary angioplasty
UR  - https://www.sciencedirect.com/science/article/pii/S110996662300146X?via%3Dihub
N2  - lt; 0.001). Intra-aortic balloon pump, extracorporeal membrane oxygenation (ECMO), and other mechanical circulatory support systems were more often used in patients with MV-pPCI. Thirty (30)-day and 1-year all-cause mortality rates were similar in the CV-pPCI and MV-pPCI groups (odds ratio, 1.01; 95% confidence interval [CI] 0.77 to 1.32; p = 0.937 and 1.1; 95% CI 0.84 to 1.44; p = 0.477). The presence of 3-vessel disease and the use of ECMO were the strongest adjusted predictors of 30-day and 1-year mortality. Conclusions Our data from an extensive all-comers registry suggests that selective use of MV-pPCI does not increase the all-cause mortality rate in patients with CS-STEMI and MVD compared to CV-pPCI.
ER  -

HLINOMAZ, Ota, Zuzana MOTOVSKA, Petr KALA, Milan HROMADKA, Jan PRECEK, Jan MROZEK, Pavel ČERVINKA, Jiri KETTNER, Jan MATEJKA, Ahmad ZOHOOR, Josef BIS a Jiří JARKOVSKÝ. Outcomes of patients with myocardial infarction and cardiogenic shock treated with culprit vessel-only versus multivessel primary PCI. \textit{Hellenic Journal of Cardiology}. AMSTERDAM: ELSEVIER, 2024, roč.~76, March-April 2024, s.~1-10. ISSN~1109-9666. Dostupné z: https://dx.doi.org/10.1016/j.hjc.2023.08.009.